BioPlus Acquisition (BioPlus Acquisition) EV-to-Revenue : (As of Jun. 06, 2024)

BioPlus Acquisition EV-to-Revenue Chart

BioPlus Acquisition Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EV-to-Revenue	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of BioPlus Acquisition's EV-to-Revenue

For the Shell Companies subindustry, BioPlus Acquisition's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioPlus Acquisition's EV-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, BioPlus Acquisition's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioPlus Acquisition's EV-to-Revenue falls into.

BioPlus Acquisition EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BioPlus Acquisition's EV-to-Revenue for today is calculated as:

BioPlus Acquisition's current Enterprise Value is $0.00 Mil.
BioPlus Acquisition's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioPlus Acquisition  (NAS:BIOSW) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BioPlus Acquisition's PS Ratiofor today is calculated as:

BioPlus Acquisition's share price for today is $0.0014.
BioPlus Acquisition's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioPlus Acquisition EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioPlus Acquisition's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPlus Acquisition (BioPlus Acquisition) Business Description